| PACT PHARMA PACT Pharma, Inc.
90692997 06 May 2021 | on 27 Feb 2024 | design of personalized adoptive cell therapies for others; none of the... Class 005 Class 005 Pharmaceutical Products The color(s) White, dark blue, light blue and green is/are claimed as a feature of the mark. Class 040 Class 040 Treatment & Processing of Materials Services "PHARMA" Class 042 Computer & Software Services & Scientific Services design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | | | PACT PACT Pharma, Inc.
90764926 09 Jun 2021 | on 26 Feb 2024 | design of personalized adoptive cell therapies for others; none of the... Class 005 Class 005 Pharmaceutical Products pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse Class 040 Class 040 Treatment & Processing of Materials Services The color(s) white, green and blue is/are claimed as a feature of the mark. Class 042 Computer & Software Services & Scientific Services design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | | | TRIFECTAR PACT Pharma, Inc.
88797913 14 Feb 2020 | on 25 Dec 2023 | Manufacturing services for others in the field of cell therapies and p... Class 040 Class 040 Treatment & Processing of Materials Services TRIFECTA | | | PACT PACT Pharma, Inc.
88686158 09 Nov 2019 | on 23 Nov 2023 | Bio-manufacturing for others, namely, manufacturing of adoptive cell a... Class 040 Class 040 Treatment & Processing of Materials Services Color is not claimed as a feature of the mark. | | | PACT PACT Pharma, Inc.
88686153 09 Nov 2019 | on 14 Nov 2023 | Design of personalized adoptive cell therapies for others; none of the... Class 042 Class 042 Computer & Software Services & Scientific Services Design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | | | PACT PACT Pharma, Inc.
88686151 09 Nov 2019 | on 14 Nov 2023 | Pharmaceutical preparations and substances for the treatment of geneti... Class 005 Class 005 Pharmaceutical Products Color is not claimed as a feature of the mark. | | | PACT PHARMA PACT Pharma, Inc.
88686154 09 Nov 2019 | on 14 Nov 2023 | Design of personalized adoptive cell therapies for others; none of the... Class 042 Class 042 Computer & Software Services & Scientific Services Design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | | | PACT PHARMA PACT Pharma, Inc.
88686147 09 Nov 2019 | on 14 Nov 2023 | Pharmaceutical preparations and substances for the treatment of geneti... Class 005 Class 005 Pharmaceutical Products "PHARMA" | | | PACT PACT Pharma, Inc.
88686146 09 Nov 2019 | on 14 Nov 2023 | Pharmaceutical preparations and substances for the treatment of geneti... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse | | | IMPACT PACT Pharma, Inc.
88686161 09 Nov 2019 | on 08 Nov 2023 | Scientific analysis services, namely, neoepitope selection; neoepitope... Class 042 Class 042 Computer & Software Services & Scientific Services Scientific analysis services, namely, neoepitope selection; neoepitope research, development and production of pharmaceuticals comprising personalized adoptive cell therapies; scientific analysis of neoepitopes; research, development and production of pharmaceuticals comprising the selection of and genetic encoding of neoepitopes; research, development and production of pharmaceuticals comprising adoptive cell therapies design of personalized adoptive cell therapies; medical analysis services, namely, detection of truncal cancer mutations in patient tumor cells; developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical product development and evaluation services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials involving neoepitopes; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Conducting early evaluations in the field of new pharmaceuticals; Providing scientific research advice regarding selection of a neoepitope for the design of a cell therapy and/or immunotherapy product | | 
